lamivudine
NDC 68999-706, lamivudine oral, solution, from Chartwell Govermental & Specialty RX, LLC..
- Product NDC
- 68999-706
- Status
- Listed
- Labeler
- Chartwell Govermental & Specialty RX, LLC.
- Dosage form
- SOLUTION
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA203564
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/68999-706 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- LAMIVUDINE10 mg/mL
Pharmacologic classes
Hepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC]; Nucleoside Reverse Transcriptase Inhibitors [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 68999-706-24 | 68999070624 | 2 TRAY in 1 BOX (68999-706-24) / 10 CUP in 1 TRAY / 30 mL in 1 CUP (68999-706-30) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/b23aea53-324b-4ff2-8736-639e4045e388
Use it
Look up 68999-706 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/68999-706 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 68999-706. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.